Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the […]
In the dynamic and ever-evolving field of oncology, Tumor-Infiltrating Lymphocytes (TILs) represent the latest in innovation […]
Japanese Market Opportunities in AI-Driven Elderly Care: Living, Health, and Medication Management The silver economy of […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
Expanding your pharmaceutical operations into Japan is a strategic move with an immense growth potential. However, […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]
Japan’s Bioeconomy Strategy 2030 marks a transformative approach to integrating biotechnology into Japan’s economic fabric. It’s […]
It all started with CAR-T cells. Or did it? Dive into the future of biotechnology by […]
Embracing Opportunities in Japan With great excitement and a sense of humble pride, I share our […]
Once a flourishing beacon of innovation and global leadership, Japan’s pharmaceutical industry has encountered significant headwinds […]